Literature DB >> 27500883

Meningeal Ewing Sarcoma/Peripheral PNET: Clinicopathological, Immunohistochemical and FISH study of four cases.

Changshu Ke1, Qiuhong Duan2, Hui Yang1, Feng Zhu2, Meng Yan1, San-Peng Xu1, Sheng Zhou1, Feng Wan3, Kai Shu3, Ting Lei3, Li-Ming Xia4.   

Abstract

Meningeal Ewing Sarcoma (ES)/peripheral primitive neuroectodermal tumor (pPNET) is a rare diagnostically challenging small round cell tumor in the CNS. This study investigates the clinical pathological features of four cases of this tumor from archives of 6 years in our hospital. Patients were within the median age of 21.5 years and male to female ratio was 1:1. The tumors distributed at the supra-tentorial location, posterior fossa and lumbar vertebral canal, usually presenting as the dura-sited nodule or having close connection with the meninges within the cranium or vertebral canal. Histopathologically, small round undifferentiated tumor cells with hypercellularities, scant cytoplasm and inconspicuous nucleoli were observed, although some components such as atypical larger vesicular nuclei, prominent nucleoli of tumor cells, necrotic foci and mesenchymal collagen proliferation forming the lobular structure, were also appreciated. Immunohistochemally, tumor cells displayed membranous positivity of CD99 (4/4), nuclear positivity of FLI-1 (4/4) and NKX2.2 (4/4), negativity of EMA, GFAP and synaptophysin expression. The histochemical PAS staining showed weak positivity in one case. Fluorescence in situ hybridization (FISH) test using EWSR1 (22q12) dual color break apart rearrangement probe showed positive results in two cases. Results suggest that using a panel of immunohistochemical markers, including NKX2.2, CD99, FLI-1, EMA, GFAP and synaptophysin, combined with the supplementary EWSR1 FISH test, helps to define the diagnosis of meningeal ES/pPNET of CNS.
© 2016 Japanese Society of Neuropathology.

Entities:  

Keywords:  Ewing sarcoma; FISH; immunohistochemistry; meningeal; pathology

Mesh:

Substances:

Year:  2016        PMID: 27500883     DOI: 10.1111/neup.12325

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  6 in total

1.  Ewing Sarcoma With Emphasis on Extra-skeletal Ewing Sarcoma: A Decade's Experience From a Single Centre in India.

Authors:  Sudha S Murthy; S Challa; Kvvn Raju; S J Rajappa; D Fonseca; S D Gundimeda; B V Rao; F Ahmed; S Kodandapani; L Nambaru; M C Mundada; R Sharma; K M Mallavarapu; V C Koppula; T S Rao
Journal:  Clin Pathol       Date:  2020-11-11

2.  Primary intracranial Ewing sarcoma/ peripheral primitive neuroectodermal tumor, an entity of unacquaintance: a series of 8 cases.

Authors:  Gauri Deshpande; Sridhar Epari; Chhavi Gupta; Omshree Shetty; Mamta Gurav; Girish Chinnaswamy; Aliasagar Moiyadi; Tejpal Gupta
Journal:  Childs Nerv Syst       Date:  2020-08-06       Impact factor: 1.475

3.  Primitive neuroectodermal tumor of the cervix diagnosed during pregnancy: a rare case report with discussion.

Authors:  Xiang Feng; Lina Zhang; Yanling Tan; Aihua Feng; Fei Luo; Mengfan Xu; Hong Ye; Hongyu Zhu; Peng Zhou; Hua Li
Journal:  BMC Pregnancy Childbirth       Date:  2021-05-18       Impact factor: 3.007

Review 4.  Primary and Metastatic Intracranial Ewing Sarcoma at Diagnosis: Retrospective International Study and Systematic Review.

Authors:  Lianne M Haveman; Andreas Ranft; Henk van den Berg; Stephanie Klco-Brosius; Ruth Ladenstein; Michael Paulussen; Heribert Juergens; Uta Dirksen; Johannes H M Merks
Journal:  Cancers (Basel)       Date:  2020-06-24       Impact factor: 6.639

5.  Cranial Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumors: A Retrospective Study Focused on Prognostic Factors and Long-Term Outcomes.

Authors:  Jun Chen; Ruimin Cheng; Fanfan Fan; Yifeng Zheng; Yakun Li; Yong Chen; Yu Wang
Journal:  Front Oncol       Date:  2019-10-09       Impact factor: 6.244

6.  Sensitive and Specific Detection of Ewing Sarcoma Minimal Residual Disease in Ovarian and Testicular Tissues in an In Vitro Model.

Authors:  Laure Chaput; Victoria Grèze; Pascale Halle; Nina Radosevic-Robin; Bruno Pereira; Lauren Véronèse; Hervé Lejeune; Philippe Durand; Guillaume Martin; Sandra Sanfilippo; Michel Canis; Justyna Kanold; Andrei Tchirkov; Florence Brugnon
Journal:  Cancers (Basel)       Date:  2019-11-17       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.